Skip to main content
search

Whitepapers

Filter

Omics Data: A Biomedical Asset Driving The Future Of Drug Discovery And Development

Effective target identification lies at the core of drug discovery. In theory, it sounds simple…

Breaking Barriers: Decoding Innovative Strategies for Functional Proteomics in Drug Discovery and Development

Unveil the intricate role of proteins in biological processes, transcending the boundaries of genomics. Explore…

Identifying Druggable Therapeutic Targets: Unveiling promising avenues in Drug discovery

Effective target identification lies at the core of drug discovery. In theory, it sounds simple…

Roadmap to Biomarker Discovery: Innovations, Opportunities, and Breakthroughs

Biomarkers are indicators of homeostasis, disease states, or pharmacological interventions. An ideal biomarker must be…

Bridging the gap between biomarker discovery and qualification through a validity index and quantified clinical outcome associations.

Biomarkers are defined as a characteristic that is objectively measured and evaluated as an indicator…

Disease landscapes: Meaningful scientific and strategic assessments for drug discovery and development

Disease landscapes include pre-clinical, clinical, and commercial data. They inform a company’s decision to proceed…

Selecting and preparing data for AI/ML predictive modeling

Find out the impact of data selection on the predictive accuracy of AI/ML models and…

Optimizing scRNA-seq data analysis with effective pipeline development

Single-cell RNA sequencing (scRNA-seq) allows genetic makeup to be studied at the level of single…

Accelerating discovery and creating value

Pharmas and biotechs are united by a common goal: discovery. Whether seeking new treatments, improved…

Please fill the form

"*" indicates required fields

This will close in 0 seconds